{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:17:39Z","timestamp":1760080659415,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jaccas.2025.105279","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:06:11Z","timestamp":1759349171000},"page":"105279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["First Post-Approval Clinical Use of F-18 Flurpiridaz With Exercise Cardiac PET in the United States"],"prefix":"10.1016","volume":"30","author":[{"given":"Suman","family":"Tandon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1850-8665","authenticated-orcid":false,"given":"Omar K.","family":"Khalique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu Q.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccas.2025.105279_bib1","doi-asserted-by":"crossref","first-page":"102175","DOI":"10.1016\/j.nuclcard.2025.102175","article-title":"18F flurpiridaz PET MPI: imaging characteristics and clinical trials","volume":"45","author":"Maddahi","year":"2025","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.jaccas.2025.105279_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2012.11.022","article-title":"Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography","volume":"61","author":"Berman","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jaccas.2025.105279_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2020.05.063","article-title":"Phase-III clinical trial of fluorine-18 flurpiridaz positron emission tomography for evaluation of coronary artery disease","volume":"76","author":"Maddahi","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.jaccas.2025.105279_bib4","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2023.08.016","article-title":"Flurpiridaz F-18 PET myocardial perfusion imaging in patients with suspected coronary artery disease","volume":"82","author":"Maddahi","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccas.2025.105279_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2025.102170","article-title":"F-18 flurpiridaz positron emission tomography myocardial perfusion imaging combined with treadmill exercise testing","volume":"45","author":"Bourque","year":"2025","journal-title":"J Nucl Cardiol"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925020601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925020601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T06:30:15Z","timestamp":1760077815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084925020601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":5,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2666084925020601"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.105279","relation":{},"ISSN":["2666-0849"],"issn-type":[{"type":"print","value":"2666-0849"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First Post-Approval Clinical Use of F-18 Flurpiridaz With Exercise Cardiac PET in the United States","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.105279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"105279"}}